SIMPPLE LTD. Releases Interim Financial Statements for 2026
SIMPPLE LTD. has filed its interim financial statements for the first half of 2026, providing insights into its operational performance in facilities management.
Colgate-Palmolive reports strong Q3 earnings, boosts outlook
Colgate-Palmolive Co. reports strong Q3 earnings driven by international sales growth, signaling competitive shifts in the personal care industry.
Clinuvel Pharmaceuticals files annual report for 2026
Clinuvel Pharmaceuticals Ltd has filed its annual report, detailing financial performance and commitments for the fiscal year ending June 30, 2026.
Oxford Square Capital reports Q3 results, updates bylaws
Oxford Square Capital Corp. announces Q3 results and amends bylaws to enhance shareholder proposal requirements, impacting governance practices.
Oppenheimer Holdings Reports Q3 2026 Earnings Decline
Oppenheimer Holdings Inc. reports a significant drop in net income for Q3 2026, reflecting challenges in retail trading and investment banking.
FirstService Corp reports strong Q3 2026 financial results
FirstService Corp announces its Q3 2026 financial results, showcasing significant revenue growth in the real estate sector.
Neo-Concept Reports First Half 2026 Financial Results
Neo-Concept International Group Holdings Ltd announces significant revenue drop and net loss for the first half of 2026, highlighting industry challenges.
OmniAb Reports Q3 2026 Financial Results in Latest Filing
OmniAb, Inc. releases its Q3 2026 financial results, showcasing performance in the commercial physical and biological research sector.
Cboe Global Markets reports Q3 results with strong growth
Cboe Global Markets files its Q3 report, showcasing growth in the security and commodity sector, impacting industry dynamics and competition.
Organon & Co. Releases Q3 2026 Results Amid Merger Plans
Organon & Co. shares Q3 2026 results, suspending earnings call due to merger with Sun Pharmaceutical. A significant shift for the pharmaceutical industry.
Oppenheimer Holdings Reports Third Quarter 2026 Results
Oppenheimer Holdings Inc. releases its Q3 2026 financial results, highlighting performance in the securities industry.
Piper Sandler reports Q3 results, declares dividend, buyback
Piper Sandler Companies announces strong Q3 results with an 18% increase in advisory revenues, a quarterly dividend, and a new share repurchase plan.
General Dynamics reports strong Q3 results, revenue up 12.9%
General Dynamics announces Q3 results with 12.9% revenue growth and 15.7% EPS increase, highlighting strong performance in the shipbuilding industry.
Aurinia Pharmaceuticals Reports Q3 Financial Results
Aurinia Pharmaceuticals shares its Q3 financial results, revealing insights into revenue and expenses, impacting its strategic direction in the pharmaceutical industry.
Mercantile Bank Corp Reports Steady Growth in Q3 Results
Mercantile Bank Corp's Q3 report shows steady growth, impacting the state commercial banking sector and prompting competitors to reassess strategies.
Vor Biopharma reports Q3 results, highlights growth strategies
Vor Biopharma Inc. releases Q3 report, showcasing financial performance and growth strategies in the biological products sector.
Organon & Co. Reports Q3 Results, Highlights Growth
Organon & Co. announces its Q3 results, showcasing growth in the pharmaceutical sector and competitive positioning in the industry.
Aurinia Pharmaceuticals Reports Q3 2026 Results, Raises Guidance
Aurinia Pharmaceuticals announces strong Q3 2026 results with revenue growth and increased guidance, signaling a positive outlook for the pharmaceutical industry.
Azenta announces strategic agreements with Elegen, acquires SynPlexity
Azenta, Inc. enhances its GENEWIZ gene synthesis capabilities through a partnership with Elegen and the acquisition of SynPlexity, boosting its market position.
Imperial Oil reports record Q3 2026 financial results
Imperial Oil Ltd announces record financial results for Q3 2026, showcasing strong performance and significant shareholder returns.